(Q50156693)

26 February 2018

title

Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. (English)

1 reference

26 February 2018

5

Fergus J Couch

1 reference

26 February 2018

10

Michael Goggins

1 reference

26 February 2018

Ralph H. Hruban

9

Ralph H Hruban

1 reference

26 February 2018

Charles J Yeo

7

Charles J Yeo

1 reference

26 February 2018

Kieran Brune

6

Kieran Brune

1 reference

26 February 2018

Hiroyuki Matsubayashi

2

Hiroyuki Matsubayashi

1 reference

26 February 2018

Carmelle D Rogers

3

Carmelle D Rogers

1 reference

26 February 2018

author name string

Sean T Martin

1

1 reference

26 February 2018

Juliet Philips

4

1 reference

26 February 2018

Scott E Kern

8

1 reference

26 February 2018

language of work or name

English

0 references

publication date

1 May 2005

1 reference

26 February 2018

published in

Oncogene

1 reference

26 February 2018

volume

24

1 reference

26 February 2018

issue

22

1 reference

26 February 2018

page(s)

3652-3656

1 reference

26 February 2018

Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Very high risk of cancer in familial Peutz-Jeghers syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

BRCA2 germline mutations in familial pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Biallelic inactivation of BRCA2 in Fanconi anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Relative frequency and morphology of cancers in STK11 mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

The National Cancer Data Base report on pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Familial pancreatic cancer: where are we in 2003?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

The genetics of FANCC and FANCG in familial pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208411

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208411

1 reference

26 February 2018

Dimensions Publication ID

1014154994

0 references

1 reference

26 February 2018